228 related articles for article (PubMed ID: 12060348)
21. Prominent and conspicuous astrocyte atrophy in human sporadic and familial Alzheimer's disease.
Rodríguez JJ; Zallo F; Gardenal E; Cabot J; Busquets X
Brain Struct Funct; 2023 Dec; 228(9):2103-2113. PubMed ID: 37730895
[TBL] [Abstract][Full Text] [Related]
22. Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CA1 neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration.
Probst A; Herzig MC; Mistl C; Ipsen S; Tolnay M
Acta Neuropathol; 2001 Dec; 102(6):636-44. PubMed ID: 11761725
[TBL] [Abstract][Full Text] [Related]
23. Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients.
Tomimoto H; Akiguchi I; Suenaga T; Nishimura M; Wakita H; Nakamura S; Kimura J
Stroke; 1996 Nov; 27(11):2069-74. PubMed ID: 8898818
[TBL] [Abstract][Full Text] [Related]
24. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury.
Calingasan NY; Erdely HA; Altar CA
Neurobiol Aging; 2002; 23(1):31-9. PubMed ID: 11755016
[TBL] [Abstract][Full Text] [Related]
25. Glial cell changes in the white matter in temporal lobe epilepsy.
Kendal C; Everall I; Polkey C; Al-Sarraj S
Epilepsy Res; 1999 Aug; 36(1):43-51. PubMed ID: 10463849
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
27. Astrocytal changes in the white matter of Jimpy mice: immunohistochemistry using antisera to glial fibrillary acidic protein.
Imamoto K
Arch Histol Jpn; 1985 Oct; 48(4):411-9. PubMed ID: 3909985
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical staining for glial fibrillary acidic protein (GFAP) after deafferentation or ischemic infarction in rat visual system: features of reactive and damaged astrocytes.
Schmidt-Kastner R; Wietasch K; Weigel H; Eysel UT
Int J Dev Neurosci; 1993 Apr; 11(2):157-74. PubMed ID: 7687085
[TBL] [Abstract][Full Text] [Related]
29. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease.
Adlard PA; West AK; Vickers JC
Neurobiol Dis; 1998 Nov; 5(5):349-56. PubMed ID: 10069577
[TBL] [Abstract][Full Text] [Related]
30. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis.
Nagy D; Kato T; Kushner PD
J Neurosci Res; 1994 Jun; 38(3):336-47. PubMed ID: 7523689
[TBL] [Abstract][Full Text] [Related]
31. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.
Su JH; Nichol KE; Sitch T; Sheu P; Chubb C; Miller BL; Tomaselli KJ; Kim RC; Cotman CW
Exp Neurol; 2000 May; 163(1):9-19. PubMed ID: 10785439
[TBL] [Abstract][Full Text] [Related]
32. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
de la Monte SM; Sohn YK; Wands JR
J Neurol Sci; 1997 Nov; 152(1):73-83. PubMed ID: 9395128
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of the S-100 beta protein in postnatal cat visual cortex: spatial and temporal patterns of expression in cortical and subcortical glia.
Dyck RH; Van Eldik LJ; Cynader MS
Brain Res Dev Brain Res; 1993 Apr; 72(2):181-92. PubMed ID: 8485842
[TBL] [Abstract][Full Text] [Related]
34. Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease.
Jørgensen OS; Brooksbank BW; Balázs R
J Neurol Sci; 1990 Aug; 98(1):63-79. PubMed ID: 1977892
[TBL] [Abstract][Full Text] [Related]
35. The enigma of cell death in neurodegenerative disorders.
Jellinger KA; Stadelmann CH
J Neural Transm Suppl; 2000; (60):21-36. PubMed ID: 11205141
[TBL] [Abstract][Full Text] [Related]
36. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease.
Moreno-Rodriguez M; Perez SE; Nadeem M; Malek-Ahmadi M; Mufson EJ
J Neuroinflammation; 2020 Feb; 17(1):58. PubMed ID: 32066474
[TBL] [Abstract][Full Text] [Related]
37. Glial cells in transected optic nerves of immature rats. II. An immunohistochemical study.
Butt AM; Kirvell S
J Neurocytol; 1996 Jun; 25(6):381-92. PubMed ID: 8835786
[TBL] [Abstract][Full Text] [Related]
38. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat.
Casha S; Yu WR; Fehlings MG
Neuroscience; 2001; 103(1):203-18. PubMed ID: 11311801
[TBL] [Abstract][Full Text] [Related]
39. Evidence for apoptotic cell death in Alzheimer's disease.
Smale G; Nichols NR; Brady DR; Finch CE; Horton WE
Exp Neurol; 1995 Jun; 133(2):225-30. PubMed ID: 7544290
[TBL] [Abstract][Full Text] [Related]
40. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
